Please note: The information displayed on this page might be outdated.
Vivoryon: Vivoryon Therapeutics has two decades of successful history in bringing pharmaceutical innovation to patients in need. Vivoryon's programs are based on dedicated research, top-level discovery and determined development. The company develops first-in-class medicines that target post-translational modifying enzymes. The pipeline contains several product candidates across various stages of development, focused on Alzheimer’s Disease and oncology.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll
Disease Space
Central Nervous System
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
<100MM
Therapeutic Modalities
Antibodies, Small Molecule
Website:
Address:
Weinbergweg 22
Halle/Saale, 06120
Germany

Company Participants at BIO CEO & Investor Conference

  • Konrad Glund, PhD, Chief Executive Officer

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

European Biotech Investor Day 2019

New York City, August 1, 2019

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.